<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M536</article-id>
      <article-id pub-id-type="publisher-id">molbank-2007-M536</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>2-(3-thienyl)-2,3-dihydrofuro[2,3-b]quinoxaline</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Anothane</surname>
            <given-names>Caleb Ahoya</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bouhfid</surname>
            <given-names>Rachid</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Essassi</surname>
            <given-names>El Mokhtar</given-names>
          </name>
          <xref rid="c1-molbank-2007-M536" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2007-M536">Laboratoire de Chimie Organique H&#xE9;t&#xE9;rocyclique, P&#xF4;le de comp&#xE9;tences Pharmacochimie, Universit&#xE9; Mohammed V-Agdal, BP: 1014 Avenue Ibn Batouta, Rabat, Morocco</aff>
      <author-notes>
        <corresp id="c1-molbank-2007-M536"><label>*</label> Author to whom correspondence should be addressed. E-mail: <email>emessassi@yahoo.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <volume>2007</volume>
      <issue>2</issue>
      <elocation-id>M536</elocation-id>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>11</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>12</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2007 by MDPI (<uri>http://www.mdpi.org/</uri>).</copyright-statement>
        <copyright-year>2007</copyright-year>
        <license>
          <p>Reproduction is permitted for noncommercial purposes.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>quinoxaline</kwd>
        <kwd>thiophene</kwd>
        <kwd>fusion</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Heterocyclic compounds particularly five and six membered ring compounds have occupied a prominent place among various classes of organic compounds for their diverse biological activities. Among a wide variety of heterocycles that have been explored for developing pharmaceutically important molecules. Quinoxaline and thiophene have played an important role in medicinal chemistry. Some of them have received considerable attention as potential antimicrobial1 [<xref ref-type="bibr" rid="B2-molbank-2007-M536">2</xref>], and antiviral [<xref ref-type="bibr" rid="B3-molbank-2007-M536">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2007-M536">4</xref>].</p>
      <p>The aim of this work is to describe the synthesis of a novel compound entitled 2-(3-thienyl)-2,3-dihydrofuro[2,3-b]quinoxaline.
	   <disp-formula>
        <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M536-i001.tif"/>
       </disp-formula></p>
      <p>The 3-methylquinoxalin-2(1<italic>H</italic>)-one <bold><underline>1</underline></bold> (1.25 mmol, 2 g) and 3-formyl-thiophene <bold><underline>2</underline></bold> (3.75 mmol, 4.8 mL) were heated in a bath oil at 150 &#xB0;C for 3h. After cooling of the reaction, the crude product was recrystallized from ethanol to obtain compound <bold><underline>3</underline></bold>.</p>
      <p>This compound was obtained in 65 % yield.</p>
	  <p>Melting point: &gt; 250 &#xB0;C.</p>
	  <p>&#xB9;H-NMR (300 MHz, DMSO-d<sub>6</sub>): 3.17, 3.20 (m, 2H, H<sub>a</sub>H<sub>b</sub>, J<sub>AB</sub> = 14.7 Hz, J<sub>AX</sub> = J<sub>BX</sub> = 7.2 Hz); 4.28 (q, 1H, H<sub>x</sub>, J<sub>AX</sub> = J<sub>BX</sub> = 7.2 Hz); 7.05-7.62 (m, 7H, H<sub>Ar</sub>).</p>
	  <p>&#xB9;&#xB3;C-NMR (300 MHz, DMSO-d<sub>6</sub>): 35.5 (CH); 48.5 (CH<sub>2</sub>); 115.4, 120.6, 123.3, 126.0, 127.8, 128.3, 129.7 (CH<sub>Ar</sub>); 131.9, 132.0, 146.4, 155.1, 160.8 (Cq).</p>
	  <p>MS (EI): M<sup>+</sup>(m/z = 254, 46%); 143 (100%).</p>
	  <p>Elemental analysis: Calculated for C<sub>14</sub>H<sub>10</sub>N<sub>2</sub>OS: C, 66.12 %; H, 3.96 %; N, 11.02 %; Found: C, 66.22 %; H, 4.01 %; N, 11.12 %;  </p>
  </body>
  <back>
    <app-group>
      <app id="app1-molbank-2007-M536">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2007-M536-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M536-s001.pdf"><label>Supplementary File 1</label></supplementary-material>
      </app>
    </app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2007-M536">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carta</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Paglietti</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Nikookar</surname>
              <given-names>M.E.R.</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sechi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zanetti</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <source>Eur. J. Med. Chem.</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>355</fpage>
          <pub-id pub-id-type="pmid">12008050</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2007-M536">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carta</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Loriga</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zanetti</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sechi</surname>
              <given-names>L.A.</given-names>
            </name>
          </person-group>
          <source>Il Farmaco</source>
          <year>2003</year>
          <volume>58</volume>
          <fpage>1251</fpage>
          <pub-id pub-id-type="pmid">14630235</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2007-M536">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fonseca</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gigante</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Gilchrist</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>De Clercq</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <source>Bioorg. Med. Chem.</source>
          <year>2004</year>
          <volume>12</volume>
          <fpage>103</fpage>
          <pub-id pub-id-type="pmid">14697775</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2007-M536">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehlstedt</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Aich</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bergman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Vallberg</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nord&#xE9;n</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gr&#xE4;slund</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <source>J. Mol. Bio.</source>
          <year>1998</year>
          <volume>278</volume>
          <fpage>31</fpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
